VOACAMINE EN TANT QU'AGENT ANTI-PALUDEEN ET AGENT ANTI-PALUDEEN CONTENANT DE LA VOACAMINE
申请人:Millenia Hope Inc.
公开号:EP1067938A1
公开(公告)日:2001-01-17
IBOGAINE FORMULATIONS
申请人:Caamtech, LLC
公开号:EP3986415A1
公开(公告)日:2022-04-27
Use of voacamine and related compounds in the treatment of malaria
申请人:Stella Leonard
公开号:US20070032460A1
公开(公告)日:2007-02-08
Voacamine, voacamine isomers, metabolites and derivatives, and related compounds can be used to, in effect, reverse multi-drug resistance in malaria and are non-toxic. The compounds can be used in combination with known drugs such as chloroquine, arthemesin and qinghaosu to prevent or treat malaria.
Voacamine and its natural and synthetic derivatives such as 16′-decarbometheoxyvoacamine, N
6
-demethylvoacamine, voacamidine, tabernamine, ervahamine A, vobasine and coronaridine are useful as anti-microbial, anti-parasitic and anti-viral agents. A basic extract of the tertiary alkaloids present in plants of the genus
Peschiera
or
Voacanga
, especially
Peschiera fuchsiaefolia
can be isolated and used directly as such an agent.